Therapeutic response to benzodiazepine in panic disorder subtypes

Sao Paulo Medical Journal

Volumn 121, Issue 2, 2003, Pages 77-80

  Valença, Alexandre Martins ^a   Nardi, Antonio Egidio ^a   Mezzasalma, Marco André ^a   Nascimento, Isabella ^a   Araüjo Zin, Walter ^a   Leão Lopes, Fabiana ^a   Versiani, Marcio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Clonazepam; Disorder; Panic; Respiration; Subtype; Treatment

Indexed keywords

ALPRAZOLAM; CLONAZEPAM; IMIPRAMINE; PLACEBO; BENZODIAZEPINE RECEPTOR AFFECTING AGENT;

ADULT; AGORAPHOBIA; ARTICLE; ASPHYXIA; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG RECEPTOR BINDING; DRUG RESPONSE; DYING; DYSPNEA; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; THORAX PAIN; ADOLESCENT; BREATHING DISORDER; COMPARATIVE STUDY; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGORAPHOBIA; CLONAZEPAM; FEMALE; GABA MODULATORS; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; RESPIRATION DISORDERS; TREATMENT OUTCOME;

EID: 0042388018     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802003000200009     Document Type: Article

References (27)

1. Klein DF. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry 1967;(16)1:118-126.
2. Zohar J, Westenberg HG. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000;403(Suppl):39-49.
3. Versiani M, Nardi AE. O tratamento da doença do pânico: 1a aula. J Bras Psiquiatr 1989;38(6)301-10.
4. Fontaine R, Chouinard G. Antipanic effect of clonazepam. [letter]. Am J Psychiatr 1984;141(1):149.
5. Ballenger JC, Burrows GD, DuPont RL, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 1988;45(5):413-22.
6. Chouinard G, Annable L, Fontaine R, Solyom L. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Psychopharmacology 1982;77(3):229-33.
7. Beaudry P, Fontaine R, Chouinard G, Annable L. Clonazepam in the treatment of patients with recurrent pain attacks. J Clin Psychiatry 1986;47(2):83-5.
8. Pollack MH. Clonazepam: a review of open clinical trials. J Clin Psychiatry 1987;48(suppl):12-5.
9. Hyman SE, Arana GW, Rosenbaum JF. Handbook of Psychiatric Drug Therapy. Boston: Little, Brown and Company; 1995.
10. Tesar GE, Rosenbaum JF, Pollack MH, et al. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry 1987;48(suppl): 16-21.
11. Svebak S, Cameron A, Levander S. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects. J Clin Psychiatry 1990;51(Suppl):14-7.
12. Briggs AC, Stretch DD, Brandon S. Subtyping of panic disorder by symptom profile. Br J Psychiatry 1993;163:201-9.
13. Lelliot P, Bass C. Symptom specificity in patients with panic. Br J Psychiatry 1990;157:593-7.
14. Bandelow B, Amering M, Benkert O, et al. Cardio-respiratory and other symptom clusters in panic disorder. Anxiety 1996;2(2):99-101.
15. First MB, Spitzer RL, Gibbon M, Williams JBM. Structured Clinical Interview Diagnostic (SCID) for DSM-IV axis I disorder-Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1997.
16. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorder-DSM-IV. 4th edition. Washington, DC: American Psychiatric Press; 1994.
17. Pols H, Zandbergen J, Lousberg H, de Loof C, Griez E. Low doses of clonazepam in the treatment of panic disorder. Can J Psychiatry 1991;36(4):302-3.
18. Davidson JR, Moroz G. Pivotal studies of clonazepam in panic disorder. Psychopharmacol Bull 1998;34(2):169-74.
19. Tesar GE, Rosenbaum JF, Pollack MH, et al. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatric 1991;52(2):69-76.
20. Tesar GE. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience. J Clin Psychiatry 1990;51(suppl):4-10.
21. Beauclair L, Fontaine R, Annable L, Holobow N, Chouinard G. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. J Clin Psychopharmacol 1994;14(2):111-8.
22. Judd FK, Burrows GD. Clonazepam in the treatment of panic disorder. Med J Aust 1986;145(1):59.
23. Rosenbaum JF, Moroz G, Bowden CL. Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. J Clin Psychopharmacol 1997;17(5):390-400.
24. Moroz G, Rosenbaum JF. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. J Clin Psychiatry 1999;60(9):604-12.
25. Valença AM, Nardi AE, Nascimento I, Mezassalma MA, Lopes FL, Zin WA. Ataques de pânico provocados pelo dióxido de carbono: estudo clínico-fenomenológico. Rev Bras Psiquiatr 2001;23(1):15-20.
26. Biber B, Alkin T. Panic disorder subtypes: differential responses to CO2 challenge. Am J Psychiatry 1999;156(5):739-44.
27. Mavissakalian MR. Phenomenology of panic attacks: responsiveness of individual symptoms to imipramine. J Clin Psychopharmacol 1996;16(3):233-7.